Related Experiment Video
Updated: Mar 21, 2026

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
A novel gene mutation in PANK2 in a patient with severe jaw-opening dystonia
Zuhal Yapici1, Nihan Hande Akcakaya2, Pinar Tekturk1
1Istanbul University, Istanbul Medical Faculty, Department of Neurology, Division of Child Neurology, Istanbul, Turkey.
Abstract:
Pantothenate kinase-associated neurodegeneration (PKAN) is a rare neurodegenerative condition. Major clinical features include progressive dystonia, pigmentary retinopathy, spasticity, and cognitive decline. The typical MRI sign of the disease, known as "eye-of-the-tiger", is what makes differential diagnosis possible. We here describe a 16-year-old male patient with PKAN presenting with severe and sustained jaw-opening dystonia which may be due to heterogeneous etiologies showing poor response to treatment. Herein, long-term follow-up and genetic results of a PKAN case who experienced severe jaw-opening dystonia are presented and discussed.
Insights
Pantothenate kinase-associated neurodegeneration (PKAN) is a rare brain disorder. This study details a PKAN case with severe jaw-opening dystonia, highlighting long-term outcomes and genetic findings.
Area of Science:
- Neuroscience and Genetics
- Rare Neurodegenerative Diseases
Background:
- Pantothenate kinase-associated neurodegeneration (PKAN) is a rare, inherited neurodegenerative disorder.
- Key features include dystonia, retinopathy, spasticity, and cognitive decline.
- The "eye-of-the-tiger" sign on MRI aids in diagnosis.
Observation:
- A 16-year-old male presented with severe, persistent jaw-opening dystonia.
- This specific dystonia presentation showed limited response to conventional treatments.
- The case highlights potential heterogeneous etiologies within PKAN.
Findings:
- Presents long-term follow-up data for a PKAN patient with severe jaw-opening dystonia.
- Includes detailed genetic analysis results for the described case.
- Discusses the clinical course and treatment challenges associated with this PKAN phenotype.
Implications:
- Enhances understanding of PKAN's diverse clinical presentations.
- Informs differential diagnosis strategies for complex dystonia cases.
- Suggests the need for tailored therapeutic approaches in PKAN management.
More Related Videos
Related Concept Videos
Cytoskeletal Linker Proteins - Plakins
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Abnormal Proliferation
Depolarizing Blockers: Pharmocokinetics

